Home
Search
Study Topics
Glossary
|
|
|
|
|
Sponsors and Collaborators: |
University of Pennsylvania National Institutes of Health (NIH) |
---|---|
Information provided by: | University of Pennsylvania |
ClinicalTrials.gov Identifier: | NCT00596440 |
A teachable moment (TM) refers to life events or transitions, such as physician visits, early detection screening feedback, pregnancy, and hospitalization for, and diagnosis of, disease, that inspire health behavior change.
Despite strong intuitive appeal of the TM concept and over 150 studies of interventions implemented in a TM, there has been little investigation of the influence of TMs for smoking, particularly for promoting smoking cessation among those indirectly affected by a TM (e.g., relatives of cancer patients). This prospective observational study using a matched-group design will assess whether a lung cancer diagnosis increases enrollment in a smoking cessation program and cessation, and reduces smoking, among the patient's relatives/spouse who smoke. We will compare enrollment in a cessation program and cessation and smoking rates in 2 groups of smokers:
1) relatives/spouses of newly-diagnosed lung cancer patients, and 2) relatives/spouses of patients with an orthopedic condition. We will also explore mediators and moderators of a lung cancer diagnosis as a TM. This study could clarify the TM concept for smoking cessation, shed light on the underlying mechanisms of TMs, and guide future development and implementation of TM-based smoking cessation interventions.
Condition | Intervention |
---|---|
Nicotine Dependence |
Drug: Transdermal nicotine patch |
Study Type: | Observational |
Study Design: | Case Control, Prospective |
Official Title: | Assessment of a Teachable Moment for Smoking Cessation |
Estimated Enrollment: | 346 |
Study Start Date: | August 2007 |
Estimated Study Completion Date: | March 2012 |
Groups/Cohorts | Assigned Interventions |
---|---|
1
Relatives of Cancer Patients
|
Drug: Transdermal nicotine patch
8 weeks; 4 weeks of 21mg, 2 weeks of 14mg, and 2 weeks of 7mg.
|
2
Relatives of Orthopedic Patients
|
Drug: Transdermal nicotine patch
8 weeks; 4 weeks of 21mg, 2 weeks of 14mg, and 2 weeks of 7mg.
|
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | Yes |
Sampling Method: | Probability Sample |
One group will be relatives/spouses of newly-diagnosed lung or head and neck cancer patients and the second group will be relatives/spouses of orthopedic patients. All participants will be regular smokers (i.e., smoke 10 cigarettes/day on average).
Inclusion Criteria:
Exclusion Criteria:
Contact: Lynne Kohler, BA | 215-746-7162 | lkohler@mail.med.upenn.edu |
Contact: Robert Schnoll, PhD | 215-746-7143 | schnoll@mail.med.upenn.edu |
United States, Pennsylvania | |
University of Pennsylvania | Recruiting |
Philadelphia, Pennsylvania, United States, 19104 | |
Contact: Lynne Kohler, BA 215-746-7162 lkohler@mail.med.upenn.edu | |
Contact: Robert A Schnoll, PhD 215-746-7143 schnoll@mail.med.upenn.edu |
Principal Investigator: | Robert A Schnoll, PhD | University of Pennsylvania |
Responsible Party: | University of Pennslyvania ( Robert Schnoll ) |
Study ID Numbers: | 805712, NIH R01CA126969 |
Study First Received: | January 8, 2008 |
Last Updated: | February 5, 2009 |
ClinicalTrials.gov Identifier: | NCT00596440 History of Changes |
Health Authority: | United States: Institutional Review Board |
smoking teachable moment cancer |
Nicotine polacrilex Smoking Nicotine Mental Disorders |
Tobacco Use Disorder Substance-Related Disorders Disorders of Environmental Origin |
Mental Disorders Tobacco Use Disorder Substance-Related Disorders Disorders of Environmental Origin |